Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ImExHS Limited ( (AU:IME) ) has shared an update.
ImExHS director Douglas Lingard has adjusted his holdings in the company following the exercise of nil‑price options into fully paid ordinary shares. He converted 20,044 options into the same number of shares at no cash consideration, increasing his direct shareholding to 346,808 shares while leaving his substantial indirect interests unchanged.
The change reflects routine equity remuneration mechanics rather than a market transaction, signalling continued alignment of the director’s interests with ordinary shareholders. With no shares sold and only options exercised, the move modestly increases Lingard’s direct exposure to ImExHS’s share price performance without altering the company’s overall capital structure in a material way.
The most recent analyst rating on (AU:IME) stock is a Hold with a A$0.42 price target. To see the full list of analyst forecasts on ImExHS Limited stock, see the AU:IME Stock Forecast page.
More about ImExHS Limited
ImExHS Limited is an Australian-listed company operating in the healthcare technology sector. It provides medical imaging and related software solutions, with a focus on radiology workflow, image management, and associated clinical services for hospitals and diagnostic providers in domestic and international markets.
Average Trading Volume: 27,896
Technical Sentiment Signal: Hold
Current Market Cap: A$21.08M
For an in-depth examination of IME stock, go to TipRanks’ Overview page.

